Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472775 (US10829493, Example 1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469288 (US10807985, Compound 63 | US10829493, Example 63 o...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472777 (US10829493, Example 3) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472778 (US10829493, Example 4) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472779 (US10829493, Example 5) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472780 (US10829493, Example 6) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472781 (US10829493, Example 7) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472782 (US10829493, Example 8) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472783 (US10829493, Example 9) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472784 (US10829493, Example 10) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472785 (US10829493, Example 11) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472786 (US10829493, Example 12) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472787 (US10829493, Example 13) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472788 (US10829493, Example 14) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472789 (US10829493, Example 15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472790 (US10829493, Example 16) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472791 (US10829493, Example 17) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472792 (US10829493, Example 18) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472793 (US10829493, Example 19) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472794 (US10829493, Example 20) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472795 (US10829493, Example 21) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472796 (US10829493, Example 22) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM472776 (US10829493, Example 2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description KIT D816V assay at the APPKM for ATP: In each well of a 384-well assay plate, 0.3 nM of untreated enzyme was incubated in a total of 13 μL of bu... | US Patent US10829493 (2020) BindingDB Entry DOI: 10.7270/Q2MP56BZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469232 (US10807985, Compound 7) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469235 (US10807985, Compound 10) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469246 (US10807985, Compound 21) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469247 (US10807985, Compound 22) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469251 (US10807985, Compound 26) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469255 (US10807985, Compound 30) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469259 (US10807985, Compound 34) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469260 (US10807985, Compound 35) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469264 (US10807985, Compound 39) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469269 (US10807985, Compound 44) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469270 (US10807985, Compound 45) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469271 (US10807985, Compound 46) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469283 (US10807985, Compound 58) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469302 (US10807985, Compound 77) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469303 (US10807985, Compound 78) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469304 (US10807985, Compound 79) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469311 (US10807985, Compound 86) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469318 (US10807985, Compound 93) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469319 (US10807985, Compound 94) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469321 (US10807985, Compound 96) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469323 (US10807985, Compound 98) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469325 (US10807985, Compound 100) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469336 (US10807985, Compound 111) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469340 (US10807985, Compound 115) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469341 (US10807985, Compound 116) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM469346 (US10807985, Compound 121) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Blueprint Medicines Corporation US Patent | Assay Description In each well of a 384-well plate, 0.7 ng/ul (8 nM) of PDGFRA D842V (ProQinase 0761-0000-1) was incubated in a total of 12.5 ul of buffer (100 mM HEPE... | US Patent US10807985 (2020) BindingDB Entry DOI: 10.7270/Q2F76GNN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Platelet-derived growth factor receptor alpha [D842V] (Homo sapiens (Human)) | BDBM504397 ((S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description KIT, KIT mutant, and PDGFRα mutant kinase profiling was performed with recombinant enzymes including wild-type KIT, KIT V560G, KIT V559D/T670I, ... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Q52SR0 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 72 total ) | Next | Last >> |